{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:25:56Z","timestamp":1793676356661,"version":"4.5.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["81971653"],"award-info":[{"award-number":["81971653"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Science Foundation of China","award":["82572319"],"award-info":[{"award-number":["82572319"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the PostDoctor Research Fund of West China Hospital, Sichuan University","award":["2025HXBH087"],"award-info":[{"award-number":["2025HXBH087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00259-026-08146-0","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:31:49Z","timestamp":1787103109000},"page":"8358-8371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deep learning-based PET\/CT mixture-of-experts model for relapse risk stratification in relapsed\/refractory classical hodgkin lymphoma: a multicenter study"],"prefix":"10.1007","volume":"53","author":[{"given":"Chong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-9004","authenticated-orcid":false,"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"issue":"18","key":"8146_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184509","volume":"15","author":"MP Randall","year":"2023","unstructured":"Randall MP, Spinner MA. Optimizing treatment for relapsed\/refractory classic Hodgkin lymphoma in the era of immunotherapy. Cancers (Basel). 2023;15(18):4509.","journal-title":"Cancers (Basel)"},{"issue":"21","key":"8146_CR2","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.3390\/jcm11216574","volume":"11","author":"E Hazane Leroyer","year":"2022","unstructured":"Hazane Leroyer E, Ziegler C, Moulin C, et al. Filling the gap: the immune therapeutic armamentarium for relapsed\/refractory hodgkin lymphoma. J Clin Med. 2022;11(21):6574.","journal-title":"J Clin Med"},{"issue":"10","key":"8146_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/2040620717728000","volume":"8","author":"L Nikolaenko","year":"2017","unstructured":"Nikolaenko L, Chen R, Herrera AF. Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma. Ther Adv Hematol. 2017;8(10):293\u2013302.","journal-title":"Ther Adv Hematol"},{"issue":"4","key":"8146_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040982","volume":"14","author":"F Massaro","year":"2022","unstructured":"Massaro F, Meuleman N, Bron D, Vercruyssen M, Maerevoet M. Brentuximab vedotin and pembrolizumab combination in patients with relapsed\/refractory Hodgkin lymphoma: a single-centre retrospective analysis. Cancers (Basel). 2022;14(4):982.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"8146_CR5","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/ajh.27470","volume":"99","author":"SM Ansell","year":"2025","unstructured":"Ansell SM. Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol. 2025;99(12):2367\u201378.","journal-title":"Am J Hematol"},{"issue":"22","key":"8146_CR6","first-page":"2727","volume":"141","author":"MA Spinner","year":"2023","unstructured":"Spinner MA, Sica RA, Tamaresis JS, et al. Improved outcomes for relapsed\/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents. Blood. 2023;141(22):2727\u201337.","journal-title":"Blood"},{"issue":"3","key":"8146_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/j.seminhematol.2016.05.003","volume":"53","author":"PJ Br\u00f6ckelmann","year":"2016","unstructured":"Br\u00f6ckelmann PJ, Angelopoulou MK, Vassilakopoulos TP. Prognostic factors in Hodgkin lymphoma. Semin Hematol. 2016;53(3):155\u201364.","journal-title":"Semin Hematol"},{"issue":"6","key":"8146_CR8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/annonc\/mdx072","volume":"28","author":"PJ Br\u00f6ckelmann","year":"2017","unstructured":"Br\u00f6ckelmann PJ, M\u00fcller H, Casasnovas O, et al. Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma. Ann Oncol. 2017;28(6):1352\u20138.","journal-title":"Ann Oncol"},{"key":"8146_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clinimag.2022.09.004","volume":"92","author":"R Eisazadeh","year":"2022","unstructured":"Eisazadeh R, Mirshahvalad SA. 18F-FDG PET\/CT prognostic role in predicting response to salvage therapy in relapsed\/refractory Hodgkin\u2019s lymphoma. Clin Imaging. 2022;92:25\u201331.","journal-title":"Clin Imaging"},{"issue":"20","key":"8146_CR10","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1182\/blood-2017-06-788877","volume":"130","author":"AJ Moskowitz","year":"2017","unstructured":"Moskowitz AJ, Sch\u00f6der H, Gavane S, et al. Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. Blood. 2017;130(20):2196\u2013203.","journal-title":"Blood"},{"issue":"1","key":"8146_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12880-023-00967-x","volume":"23","author":"T Yang","year":"2023","unstructured":"Yang T, Liu S, Zuo R, et al. Prognostic role of pretreatment 18F-FDG PET\/CT and hematological parameters in relapsed\/refractory Hodgkin lymphoma patients treated with immune checkpoint inhibitors and chemotherapy: a dual-center cohort study. BMC Med Imaging. 2023;23(1):12.","journal-title":"BMC Med Imaging"},{"issue":"5","key":"8146_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1007\/s00259-024-07024-x","volume":"52","author":"C Jiang","year":"2025","unstructured":"Jiang C, Jiang Z, Zhang X, et al. Robust and interpretable deep learning system for prognostic stratification of extranodal natural killer\/T-cell lymphoma. Eur J Nucl Med Mol Imaging. 2025;52(5):1739\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8146_CR13","doi-asserted-by":"publisher","first-page":"112204","DOI":"10.1016\/j.ejrad.2025.112204","volume":"190","author":"MM Mehrabi Nejad","year":"2025","unstructured":"Mehrabi Nejad MM, Ghanbari Boroujeni MR, Hayati A, Dashti F, Udupa JK, Torigian DA. Performance of AI methods in PET-based imaging for outcome prediction in lymphoma: A systematic review and meta-analysis. Eur J Radiol. 2025;190:112204.","journal-title":"Eur J Radiol"},{"key":"8146_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-026-07838-x","author":"H Huang","year":"2026","unstructured":"Huang H, Zhang T, Jiang Z, et al. A deep learning PET\/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study. Eur J Nucl Med Mol Imaging. 2026. https:\/\/doi.org\/10.1007\/s00259-026-07838-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"8146_CR15","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1007\/s00259-023-06405-y","volume":"50","author":"C Jiang","year":"2023","unstructured":"Jiang C, Qian C, Jiang Z, et al. Robust deep learning-based PET prognostic imaging biomarker for DLBCL patients: a multicenter study. Eur J Nucl Med Mol Imaging. 2023;50(13):3949\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"8146_CR16","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.1182\/bloodadvances.2023010404","volume":"7","author":"J Driessen","year":"2023","unstructured":"Driessen J, Zwezerijnen GJC, Sch\u00f6der H, et al. Prognostic model using 18F-FDG PET radiomics predicts progression-free survival in relapsed\/refractory Hodgkin lymphoma. Blood Adv. 2023;7(21):6732\u201343.","journal-title":"Blood Adv"},{"issue":"7","key":"8146_CR17","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s00259-025-07090-9","volume":"52","author":"C Jiang","year":"2025","unstructured":"Jiang C, Jiang Z, Zhang Z, et al. An explainable transformer model integrating PET and tabular data for histologic grading and prognosis of follicular lymphoma: a multi-institutional digital biopsy study. Eur J Nucl Med Mol Imaging. 2025;52(7):2384\u201396.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"8146_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41551-023-01045-x","volume":"7","author":"HY Zhou","year":"2023","unstructured":"Zhou HY, Yu Y, Wang C, et al. A transformer-based representation-learning model with unified processing of multimodal input for clinical diagnostics. Nat Biomed Eng. 2023;7(6):743\u201355.","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"8146_CR19","doi-asserted-by":"publisher","first-page":"12113","DOI":"10.1109\/TPAMI.2023.3275156","volume":"45","author":"P Xu","year":"2023","unstructured":"Xu P, Zhu X, Clifton DA. Multimodal learning with transformers: a survey. IEEE Trans Pattern Anal Mach Intell. 2023;45(10):12113\u201332.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"10","key":"8146_CR20","first-page":"1","volume":"58","author":"J Liu","year":"2026","unstructured":"Liu J, Tang P, Wang W, et al. A survey on inference optimization techniques for mixture of experts models[J]. ACM-CSUR. 2026;58(10):1\u201337.","journal-title":"ACM-CSUR"},{"key":"8146_CR21","doi-asserted-by":"crossref","unstructured":"Xiong C, Chen H, Zheng H et al. Mome: Mixture of multimodal experts for cancer survival prediction[C]\/\/International Conference on Medical Image Computing and Computer-Assisted Intervention. Cham: Springer Nature Switzerland, 2024: 318\u2013328.","DOI":"10.1007\/978-3-031-72083-3_30"},{"key":"8146_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.inffus.2025.103521","author":"W Zhang","year":"2025","unstructured":"Zhang W, Xu W, Chen T, et al. Integrating images and genomics for multi-modal cancer survival analysis via mixture of experts. Inf Fusion. 2025. https:\/\/doi.org\/10.1016\/j.inffus.2025.103521.","journal-title":"Inf Fusion"},{"issue":"4","key":"8146_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.21037\/tlcr-23-737","volume":"13","author":"N Lou","year":"2024","unstructured":"Lou N, Cui X, Lin X, et al. Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data[J]. Translational lung cancer Res. 2024;13(4):706\u201320.","journal-title":"Translational lung cancer Res"},{"key":"8146_CR24","doi-asserted-by":"crossref","unstructured":"Jiang Y, Shen Y. M4oe: A foundation model for medical multimodal image segmentation with mixture of experts[C]\/\/international conference on medical image computing and computer-assisted intervention. Cham: Springer Nature Switzerland, 2024:621\u2013631.","DOI":"10.1007\/978-3-031-72390-2_58"},{"key":"8146_CR25","doi-asserted-by":"crossref","unstructured":"Jiang C, Pan Y, Liu M et al. PET-diffusion: Unsupervised PET enhancement based on the latent diffusion model[C]\/\/International Conference on Medical Image Computing and Computer-Assisted Intervention. Cham: Springer Nature Switzerland, 2023:3\u201312.","DOI":"10.1007\/978-3-031-43907-0_1"},{"key":"8146_CR26","unstructured":"Cheng J, Ye J, Deng Z et al. Sam-med2d[J]. arXiv preprint arXiv:2308.16184, 2023."},{"key":"8146_CR27","doi-asserted-by":"crossref","unstructured":"Wang Z, Wu Z, Agarwal D et al. Medclip: Contrastive learning from unpaired medical images and text[C]\/\/Proceedings of the 2022 Conference on Empirical Methods in Natural Language Processing. 2022:3876\u20133887.","DOI":"10.18653\/v1\/2022.emnlp-main.256"},{"issue":"1","key":"8146_CR28","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1038\/s41467-025-62385-7","volume":"16","author":"C Wu","year":"2025","unstructured":"Wu C, Zhang X, Zhang Y, et al. Towards generalist foundation model for radiology by leveraging web-scale 2d&3d medical data[J]. Nat Commun. 2025;16(1):7866.","journal-title":"Nat Commun"},{"key":"8146_CR29","unstructured":"Collins GS, Moons KG, Dhiman P, Riley RD, Beam AL, Van Calster B et al. TRIPOD AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024:385."},{"key":"8146_CR30","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786\u20139.","journal-title":"Cancer Res"},{"issue":"1","key":"8146_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s42256-024-00965-w","volume":"7","author":"F P\u00e9rez-Garc\u00eda","year":"2025","unstructured":"P\u00e9rez-Garc\u00eda F, Sharma H, Bond-Taylor S, et al. Exploring scalable medical image encoders beyond text supervision[J]. Nat Mach Intell. 2025;7(1):119\u201330.","journal-title":"Nat Mach Intell"},{"issue":"14","key":"8146_CR32","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1097\/CM9.0000000000003699","volume":"138","author":"M Fang","year":"2025","unstructured":"Fang M, Wang Z, Pan S, et al. Large models in medical imaging: Advances and prospects[J]. Chin Med J. 2025;138(14):1647\u201364.","journal-title":"Chin Med J"},{"key":"8146_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115073","volume":"213","author":"C Rossi","year":"2024","unstructured":"Rossi C, Manson G, Marouf A, et al. Classic Hodgkin lymphoma: the LYSA pragmatic guidelines. Eur J Cancer. 2024;213:115073.","journal-title":"Eur J Cancer"},{"issue":"2","key":"8146_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2967\/jnumed.121.262464","volume":"63","author":"F Orlhac","year":"2022","unstructured":"Orlhac F, Eertink JJ, Cottereau AS, et al. A guide to ComBat harmonization of imaging biomarkers in multicenter studies[J]. J Nucl Med. 2022;63(2):172\u20139.","journal-title":"J Nucl Med"},{"issue":"1","key":"8146_CR35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12916-026-04865-1","volume":"24","author":"C Jiang","year":"2026","unstructured":"Jiang C, Zhang Z, Jiang Z, et al. Interpretable multimodal PET\/CT-EHR fusion via mixture-of-experts for prognostic stratification in mantle cell lymphoma: a multicenter study. BMC Med. 2026;24(1):330.","journal-title":"BMC Med"},{"issue":"12","key":"8146_CR36","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.bbmt.2013.09.018","volume":"19","author":"T Hahn","year":"2013","unstructured":"Hahn T, McCarthy PL, Carreras J, et al. Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma. Biol Blood Marrow Transpl. 2013;19(12):1740\u20134.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"8146_CR37","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3324\/haematol.2021.278311","volume":"107","author":"Y Nieto","year":"2022","unstructured":"Nieto Y, Gruschkus S, Valdez BC, et al. Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica. 2022;107(4):899\u2013908.","journal-title":"Haematologica"},{"issue":"1127","key":"8146_CR38","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210448","volume":"94","author":"M Meignan","year":"2021","unstructured":"Meignan M, Cottereau AS, Specht L, Mikhaeel NG. Total tumor burden in lymphoma - an evolving strong prognostic parameter. Br J Radiol. 2021;94(1127):20210448.","journal-title":"Br J Radiol"},{"issue":"7","key":"8146_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15072056","volume":"15","author":"C Ortega","year":"2023","unstructured":"Ortega C, Eshet Y, Prica A, et al. Combination of FDG PET\/CT radiomics and clinical parameters for outcome prediction in patients with Hodgkin\u2019s lymphoma. Cancers (Basel). 2023;15(7):2056.","journal-title":"Cancers (Basel)"},{"key":"8146_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6347404","volume":"2021","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhu Y, Chen Z, Li J, Sang S, Deng S. Radiomic features of 18F-FDG PET in Hodgkin lymphoma are predictive of outcomes. Contrast Media Mol Imaging. 2021;2021:6347404.","journal-title":"Contrast Media Mol Imaging"},{"issue":"22","key":"8146_CR41","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","volume":"131","author":"V Spina","year":"2018","unstructured":"Spina V, Bruscaggin A, Cuccaro A, et al. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. Blood. 2018;131(22):2413\u201325.","journal-title":"Blood"},{"issue":"1","key":"8146_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/bloodadvances.2025017107","volume":"10","author":"Y Yin","year":"2026","unstructured":"Yin Y, Rai S, Jiang A, et al. Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq. Blood Adv. 2026;10(1):29\u201338.","journal-title":"Blood Adv"},{"issue":"1","key":"8146_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-08223-8","volume":"15","author":"C Cui","year":"2025","unstructured":"Cui C, Cao J, Li Y, et al. A proof of concept study of 18F-FDG PET\/CT patient-level radiomics identify refractory\/relapsed diffuse large B-cell lymphoma. Sci Rep. 2025;15(1):33914.","journal-title":"Sci Rep"},{"issue":"12","key":"8146_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210095","volume":"24","author":"F Munir","year":"2023","unstructured":"Munir F, Hardit V, Sheikh IN, et al. Classical Hodgkin lymphoma: from past to future-a comprehensive review of pathophysiology and therapeutic advances. Int J Mol Sci. 2023;24(12):10095.","journal-title":"Int J Mol Sci"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08146-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08146-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:27Z","timestamp":1793672967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08146-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8146"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08146-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the institutional review board of West China Hospital, Sichuan University.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the nature of retrospective study, written informed consent was waived.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}